Maroulakou IG - Search Results

1

Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.

Kenney NJ, Smith GH, Maroulakou IG, Green JH, Muller WJ, Callahan R, Salomon DS, Dickson RB. Kenney NJ, et al. Among authors: maroulakou ig. Mol Carcinog. 1996 Jan;15(1):44-56. doi: 10.1002/(SICI)1098-2744(199601)15:1<44::AID-MC7>3.0.CO;2-S. Mol Carcinog. 1996. PMID: 8561865

2

Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.

Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG. Bowe DB, et al. Among authors: maroulakou ig. Oncogene. 2002 Jan 10;21(2):291-8. doi: 10.1038/sj.onc.1205025. Oncogene. 2002. PMID: 11803472

3

Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice.

Maroulakou IG, Shibata MA, Jorcyk CL, Chen XX, Green JE. Maroulakou IG, et al. Mol Carcinog. 1997 Oct;20(2):168-74. doi: 10.1002/(sici)1098-2744(199710)20:2<168::aid-mc3>3.0.co;2-j. Mol Carcinog. 1997. PMID: 9364206

4

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

Maroulakou IG, Anver M, Garrett L, Green JE. Maroulakou IG, et al. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11236-40. doi: 10.1073/pnas.91.23.11236. Proc Natl Acad Sci U S A. 1994. PMID: 7972041 Free PMC article.

5

p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.

Shibata MA, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM, Green JE. Shibata MA, et al. Among authors: maroulakou ig. Cancer Res. 1996 Jul 1;56(13):2998-3003. Cancer Res. 1996. PMID: 8674054

6

Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome.

Georgiou P, Maroulakou I, Green J, Dantis P, Romanospica V, Kottaridis S, Lautenberger J, Watson D, Papas T, Fischinger P, Bhat N. Georgiou P, et al. Int J Oncol. 1996 Jul;9(1):9-18. Int J Oncol. 1996. PMID: 21541474

7

Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.

Maroulakou IG, Oemler W, Naber SP, Tsichlis PN. Maroulakou IG, et al. Cancer Res. 2007 Jan 1;67(1):167-77. doi: 10.1158/0008-5472.CAN-06-3782. Cancer Res. 2007. PMID: 17210696

8

Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.

Yoshidome K, Shibata MA, Maroulakou IG, Liu ML, Jorcyk CL, Gold LG, Welch VN, Green JE. Yoshidome K, et al. Among authors: maroulakou ig. Int J Oncol. 1998 Feb;12(2):449-53. Int J Oncol. 1998. PMID: 9458374 Review.

9

Isolation and characterization of a novel gene expressed in multiple cancers.

Chen SL, Maroulakou IG, Green JE, Romano-Spica V, Modi W, Lautenberger J, Bhat NK. Chen SL, et al. Among authors: maroulakou ig. Oncogene. 1996 Feb 15;12(4):741-51. Oncogene. 1996. PMID: 8632896

10

The down-regulated in adenoma (DRA) gene encodes an intestine-specific membrane glycoprotein.

Byeon MK, Westerman MA, Maroulakou IG, Henderson KW, Suster S, Zhang XK, Papas TS, Vesely J, Willingham MC, Green JE, Schweinfest CW. Byeon MK, et al. Among authors: maroulakou ig. Oncogene. 1996 Jan 18;12(2):387-96. Oncogene. 1996. PMID: 8570216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters